|
EP1132471A3
(de)
|
1989-09-12 |
2001-11-28 |
F. Hoffmann-La Roche Ag |
TNF-bindende Proteine
|
|
US6656466B1
(en)
*
|
1995-06-06 |
2003-12-02 |
Genetech, Inc. |
Human tumor necrosis factor—immunoglobulin(TNFR1-IgG1) chimera composition
|
|
US5705364A
(en)
†
|
1995-06-06 |
1998-01-06 |
Genentech, Inc. |
Mammalian cell culture process
|
|
JP4306813B2
(ja)
|
1995-09-19 |
2009-08-05 |
アスビオファーマ株式会社 |
動物細胞の新規培養方法
|
|
TR199802238T2
(xx)
*
|
1996-05-08 |
1999-02-22 |
F. Hoffmann-La Roche Ag |
Astımın TNFR-Ig ile tedavisi.
|
|
DE59813187D1
(de)
*
|
1997-12-03 |
2005-12-15 |
Roche Diagnostics Gmbh |
Verfahren zur herstellung von polypeptiden mit geeigneter glykosilierung
|
|
US6140445A
(en)
*
|
1998-04-17 |
2000-10-31 |
Crompton Corporation |
Silane functional oligomer
|
|
US6528286B1
(en)
*
|
1998-05-29 |
2003-03-04 |
Genentech, Inc. |
Mammalian cell culture process for producing glycoproteins
|
|
ES2255765T3
(es)
*
|
1998-05-29 |
2006-07-01 |
Genentech, Inc. |
Procedimiento de cultivo de celulas para la produccion de glicoproteinas.
|
|
TR200504220T2
(tr)
|
1998-12-17 |
2007-04-24 |
Biogen Idec Ma Inc. |
Aktif limfotoksin-beta reseptör imunoglobülin şimeAktif limfotoksin-beta reseptör imunoglobülin şimerik proteinlerinin yüksek düzey ifadesi ve saflaştrik proteinlerinin yüksek düzey ifadesi ve saflaştırılması için bir yöntem.ırılması için bir yöntem.
|
|
GB9828624D0
(en)
*
|
1998-12-23 |
1999-02-17 |
Glaxo Group Ltd |
Production of proteins
|
|
KR100475417B1
(ko)
*
|
1998-12-30 |
2005-07-18 |
씨제이 주식회사 |
시알산 함량이 높은 재조합 당단백질의 제조방법
|
|
US7294481B1
(en)
*
|
1999-01-05 |
2007-11-13 |
Immunex Corporation |
Method for producing recombinant proteins
|
|
EP1171615B1
(en)
|
1999-04-26 |
2006-12-13 |
Genentech, Inc. |
Cell culture process for glycoproteins
|
|
US6261805B1
(en)
*
|
1999-07-15 |
2001-07-17 |
Boyce Thompson Institute For Plant Research, Inc. |
Sialyiation of N-linked glycoproteins in the baculovirus expression vector system
|
|
KR100394474B1
(ko)
*
|
1999-12-18 |
2003-08-09 |
동아제약 주식회사 |
동물세포에서 재조합 당단백질의 연속식 대량생산 방법
|
|
ES2256234T3
(es)
*
|
2000-05-16 |
2006-07-16 |
Lipoxen Technologies Limited |
Derivatizacion de proteinas en solucion acuosa.
|
|
US20030170813A1
(en)
*
|
2000-07-05 |
2003-09-11 |
Kenichi Suga |
Process for producing glycoprotein
|
|
US20030040095A1
(en)
*
|
2001-03-16 |
2003-02-27 |
Achille Arini |
Method for the production of pharmaceutically active recombinant proteins
|
|
EP1404813A4
(en)
*
|
2001-06-13 |
2004-11-24 |
Genentech Inc |
METHOD FOR CULTIVATING ANIMAL CELLS AND POLYPEPTIDE PRODUCTION IN ANIMAL CELLS
|
|
JP2005521401A
(ja)
*
|
2002-03-27 |
2005-07-21 |
イミュネックス・コーポレーション |
ポリペプチド産生を増加させる方法
|
|
US20030190710A1
(en)
*
|
2002-03-28 |
2003-10-09 |
Devries Ruth L. |
Control of glycoforms in IgG
|
|
US7067279B1
(en)
*
|
2002-08-23 |
2006-06-27 |
Immunex Corporation |
Cell culture performance with betaine
|
|
US6974681B1
(en)
|
2002-08-23 |
2005-12-13 |
Immunex Corporation |
Cell culture performance with vanadate
|
|
US6924124B1
(en)
*
|
2002-08-23 |
2005-08-02 |
Immunex Corporation |
Feeding strategies for cell culture
|
|
CA2508375C
(en)
*
|
2002-12-02 |
2014-05-27 |
Abgenix, Inc. |
Antibodies directed to tumor necrosis factor and uses thereof
|
|
SI1576182T2
(sl)
*
|
2002-12-23 |
2020-07-31 |
Bristol-Myers Squibb Company |
Izboljšava kvalitete izdelka v procesih pridelave beljakovin v celični kulturi sesalcev
|
|
TWI312368B
(en)
*
|
2002-12-23 |
2009-07-21 |
Bristol Myers Squibb Compan |
Mammalian cell culture processes for protein production
|
|
CA2522779A1
(en)
*
|
2003-04-25 |
2004-11-11 |
Immunex Corporation |
Inducers of recombinant protein expression
|
|
SG147468A1
(en)
|
2003-10-24 |
2008-11-28 |
Selexis Sa |
High efficiency gene transfer and expression in mammalian cells by a multiple transfection procedure of matrix attachment region sequences
|
|
JP2008504009A
(ja)
*
|
2003-12-23 |
2008-02-14 |
アプライド リサーチ システムズ エーアールエス ホールディング ナームロゼ フェンノートシャップ |
腫瘍壊死因子結合蛋白質を生産する方法
|
|
EP1709185A1
(en)
*
|
2003-12-31 |
2006-10-11 |
Samyang Genex Corporation |
Method for mass production of secondary metabolites in plant cell culture by treatment of an alkanoic acid or salt thereof
|
|
EP1725673A1
(en)
*
|
2004-02-13 |
2006-11-29 |
Glycotope Gmbh |
Sialytated glycoproteins-process conditions and an efficient method for their production
|
|
US7300773B2
(en)
*
|
2004-08-27 |
2007-11-27 |
Wyeth Research Ireland Limited |
Production of TNFR-Ig
|
|
TWI384069B
(zh)
*
|
2004-08-27 |
2013-02-01 |
Pfizer Ireland Pharmaceuticals |
多胜肽之製法
|
|
US7335491B2
(en)
*
|
2004-08-27 |
2008-02-26 |
Wyeth Research Ireland Limited |
Production of anti-abeta
|
|
WO2006125207A2
(en)
*
|
2005-05-19 |
2006-11-23 |
Amgen Inc. |
Compositions and methods for increasing the stability of antibodies
|
|
JP2008541746A
(ja)
*
|
2005-06-03 |
2008-11-27 |
ビオヴィトルム・アクチボラゲット（プブリクト） |
新規プロセス
|
|
KR100670105B1
(ko)
|
2005-06-29 |
2007-01-17 |
주식회사 셀트리온 |
콩가수분해물의 저분자량 분획을 이용하여 시알산 함량이증가된 에리스로포이에틴을 생산하는 방법 및 그에 의하여생산된 시알산 함량이 증가된 에리스로포이에틴
|
|
WO2008057634A2
(en)
*
|
2006-10-26 |
2008-05-15 |
The Rockefeller University |
Polypeptides with enhanced anti-inflammatory and decreased cytotoxic properties and relating methods
|
|
US8470318B2
(en)
|
2005-11-07 |
2013-06-25 |
The Rockefeller University |
Polypeptides with enhanced anti-inflammatory and decreased cytotoxic properties and relating methods
|
|
AR058568A1
(es)
|
2005-12-20 |
2008-02-13 |
Bristol Myers Squibb Co |
Metodos para producir una composicion con moleculas ctla4-ig a partir de un medio de cultivo
|
|
JP5096369B2
(ja)
|
2005-12-20 |
2012-12-12 |
ブリストル−マイヤーズ スクイブ カンパニー |
組成物および組成物の製造方法
|
|
US20070190057A1
(en)
|
2006-01-23 |
2007-08-16 |
Jian Wu |
Methods for modulating mannose content of recombinant proteins
|
|
JP5199886B2
(ja)
*
|
2006-01-26 |
2013-05-15 |
レコファーマ アーベー |
ウイルスの接着を阻害するための組成物および方法
|
|
CN101432301B
(zh)
*
|
2006-04-05 |
2014-01-08 |
洛克菲勒大学 |
具有增强的抗炎性和降低的细胞毒性特性的多肽以及相关方法
|
|
CN101541950A
(zh)
*
|
2006-07-13 |
2009-09-23 |
惠氏公司 |
糖蛋白的产生
|
|
US8911964B2
(en)
|
2006-09-13 |
2014-12-16 |
Abbvie Inc. |
Fed-batch method of making human anti-TNF-alpha antibody
|
|
CN103276033A
(zh)
*
|
2006-09-13 |
2013-09-04 |
雅培制药有限公司 |
细胞培养改良
|
|
US20080145893A1
(en)
*
|
2006-09-17 |
2008-06-19 |
Excellegene Sa |
Method for producing a recombinant protein at high specific productivity, high batch yield and high volumetric yield by means of transient transfection
|
|
WO2008069244A1
(ja)
*
|
2006-12-05 |
2008-06-12 |
Kyowa Hakko Kogyo Co., Ltd. |
糖蛋白質組成物の製造方法
|
|
EP2135081B1
(en)
*
|
2007-04-16 |
2012-12-05 |
Momenta Pharmaceuticals, Inc. |
Methods related to cell surface glycosylation
|
|
TW200902708A
(en)
|
2007-04-23 |
2009-01-16 |
Wyeth Corp |
Methods of protein production using anti-senescence compounds
|
|
US20090023186A1
(en)
*
|
2007-07-22 |
2009-01-22 |
Excellgene Sa |
Use of valproic acid for enhancing production of recombinant proteins in mammalian cells
|
|
US20090042253A1
(en)
*
|
2007-08-09 |
2009-02-12 |
Wyeth |
Use of perfusion to enhance production of fed-batch cell culture in bioreactors
|
|
TWI395593B
(zh)
|
2008-03-06 |
2013-05-11 |
Halozyme Inc |
可活化的基質降解酵素之活體內暫時性控制
|
|
EP4269578B8
(en)
*
|
2008-03-06 |
2024-07-17 |
Halozyme, Inc. |
Soluble hyaluronidase composition
|
|
WO2009126564A1
(en)
|
2008-04-07 |
2009-10-15 |
Bayer Healthcare Llc |
Methods of recombinant production of glycoproteins
|
|
EP2279410B1
(en)
|
2008-04-22 |
2015-11-11 |
The Rockefeller University |
Methods of identifying anti-inflammatory compounds
|
|
HRP20180738T1
(hr)
|
2008-09-15 |
2018-06-15 |
F. Hoffmann - La Roche Ag |
Pripravci i postupci za regulaciju stanične osmolarnosti
|
|
CN104974251A
(zh)
|
2008-10-20 |
2015-10-14 |
Abbvie公司 |
在抗体纯化过程中的病毒灭活
|
|
CN105111309A
(zh)
*
|
2008-10-20 |
2015-12-02 |
Abbvie公司 |
使用a蛋白亲和层析分离和纯化抗体
|
|
CN102307993B
(zh)
|
2008-12-09 |
2014-06-25 |
哈洛齐梅公司 |
延长的可溶性ph20多肽及其用途
|
|
WO2010102262A1
(en)
*
|
2009-03-06 |
2010-09-10 |
Halozyme, Inc. |
Temperature sensitive mutants of matrix metalloprotease 1 und uses thereof
|
|
US9540426B2
(en)
|
2009-10-06 |
2017-01-10 |
Bristol-Myers Squibb Company |
Mammalian cell culture processes for protein production
|
|
ES2622366T3
(es)
|
2009-10-26 |
2017-07-06 |
F. Hoffmann-La Roche Ag |
Procedimiento para la producción de una inmunoglobulina glucosilada
|
|
WO2011062926A2
(en)
|
2009-11-17 |
2011-05-26 |
Medarex, Inc. |
Methods for enhanced protein production
|
|
CA2782320A1
(en)
*
|
2009-12-02 |
2011-06-09 |
Acceleron Pharma Inc. |
Compositions and methods for increasing serum half-life of fc fusion proteins
|
|
NZ601790A
(en)
*
|
2010-02-24 |
2014-03-28 |
Zymenex As |
Process for production and purification of recombinant lysosomal alpha-mannosidase
|
|
JPWO2012017925A1
(ja)
|
2010-08-02 |
2013-10-03 |
協和発酵キリン株式会社 |
物質の製造方法
|
|
CA2829774C
(en)
|
2011-03-14 |
2019-09-24 |
National Research Council Of Canada |
Method of viral production in cells
|
|
EP2702077A2
(en)
|
2011-04-27 |
2014-03-05 |
AbbVie Inc. |
Methods for controlling the galactosylation profile of recombinantly-expressed proteins
|
|
KR101591671B1
(ko)
|
2011-04-29 |
2016-02-04 |
바이오콘 리서치 리미티드 |
항체의 이질성을 감소시키는 방법 및 그 항체의 제조방법
|
|
WO2012170938A1
(en)
|
2011-06-08 |
2012-12-13 |
Acceleron Pharma Inc. |
Compositions and methods for increasing serum half-life
|
|
US9150645B2
(en)
|
2012-04-20 |
2015-10-06 |
Abbvie, Inc. |
Cell culture methods to reduce acidic species
|
|
WO2013158273A1
(en)
|
2012-04-20 |
2013-10-24 |
Abbvie Inc. |
Methods to modulate c-terminal lysine variant distribution
|
|
US9067990B2
(en)
|
2013-03-14 |
2015-06-30 |
Abbvie, Inc. |
Protein purification using displacement chromatography
|
|
US9249182B2
(en)
|
2012-05-24 |
2016-02-02 |
Abbvie, Inc. |
Purification of antibodies using hydrophobic interaction chromatography
|
|
CN102839157A
(zh)
*
|
2012-07-12 |
2012-12-26 |
扬州大学 |
稳定共表达hST3GalIV和β1-4GalT1的MDCK细胞系及构建方法和应用
|
|
AU2013309506A1
(en)
|
2012-09-02 |
2015-03-12 |
Abbvie Inc. |
Methods to control protein heterogeneity
|
|
US9512214B2
(en)
|
2012-09-02 |
2016-12-06 |
Abbvie, Inc. |
Methods to control protein heterogeneity
|
|
NO2760138T3
(enExample)
|
2012-10-01 |
2018-08-04 |
|
|
|
US20140106405A1
(en)
*
|
2012-10-15 |
2014-04-17 |
Bristol-Myers Squibb Company |
Mammalian cell culture processes for protein production
|
|
JP2015531244A
(ja)
|
2012-10-15 |
2015-11-02 |
ブリストル−マイヤーズ スクイブ カンパニーＢｒｉｓｔｏｌ−Ｍｙｅｒｓ Ｓｑｕｉｂｂ Ｃｏｍｐａｎｙ |
タンパク質を製造するための哺乳動物細胞培養方法
|
|
EP2830651A4
(en)
|
2013-03-12 |
2015-09-02 |
Abbvie Inc |
HUMAN ANTIBODIES THAT BIND TNF-ALPHA AND PREPARATION METHODS
|
|
US9017687B1
(en)
|
2013-10-18 |
2015-04-28 |
Abbvie, Inc. |
Low acidic species compositions and methods for producing and using the same using displacement chromatography
|
|
US9217168B2
(en)
|
2013-03-14 |
2015-12-22 |
Momenta Pharmaceuticals, Inc. |
Methods of cell culture
|
|
US9499614B2
(en)
|
2013-03-14 |
2016-11-22 |
Abbvie Inc. |
Methods for modulating protein glycosylation profiles of recombinant protein therapeutics using monosaccharides and oligosaccharides
|
|
WO2014159579A1
(en)
|
2013-03-14 |
2014-10-02 |
Abbvie Inc. |
MUTATED ANTI-TNFα ANTIBODIES AND METHODS OF THEIR USE
|
|
AR095196A1
(es)
|
2013-03-15 |
2015-09-30 |
Regeneron Pharma |
Medio de cultivo celular libre de suero
|
|
CA2913687C
(en)
|
2013-07-04 |
2022-12-13 |
F. Hoffmann-La Roche Ag |
Interference-suppressed immunoassay to detect anti-drug antibodies in serum samples
|
|
CA2917484A1
(en)
|
2013-07-06 |
2015-01-15 |
Cadila Healthcare Limited |
Improved process for production of monoclonal antibodies
|
|
EP3052640A2
(en)
|
2013-10-04 |
2016-08-10 |
AbbVie Inc. |
Use of metal ions for modulation of protein glycosylation profiles of recombinant proteins
|
|
US8946395B1
(en)
|
2013-10-18 |
2015-02-03 |
Abbvie Inc. |
Purification of proteins using hydrophobic interaction chromatography
|
|
US9085618B2
(en)
|
2013-10-18 |
2015-07-21 |
Abbvie, Inc. |
Low acidic species compositions and methods for producing and using the same
|
|
US9181337B2
(en)
|
2013-10-18 |
2015-11-10 |
Abbvie, Inc. |
Modulated lysine variant species compositions and methods for producing and using the same
|
|
US20150139988A1
(en)
|
2013-11-15 |
2015-05-21 |
Abbvie, Inc. |
Glycoengineered binding protein compositions
|
|
KR102280638B1
(ko)
*
|
2014-02-27 |
2021-07-22 |
에프. 호프만-라 로슈 아게 |
재조합 당단백질 제조에서의 세포 성장 및 글리코실화의 조절
|
|
JP6652334B2
(ja)
|
2014-05-31 |
2020-02-19 |
Ｊｃｒファーマ株式会社 |
ウリジンとｎ−アセチル−ｄ−マンノサミンとを含有する培地
|
|
CN106536746A
(zh)
*
|
2014-06-03 |
2017-03-22 |
鲁宾有限公司 |
用于生产蛋白的细胞培养方法
|
|
US20160130324A1
(en)
|
2014-10-31 |
2016-05-12 |
Shire Human Genetic Therapies, Inc. |
C1 Inhibitor Fusion Proteins and Uses Thereof
|
|
KR102007930B1
(ko)
|
2014-12-31 |
2019-08-06 |
주식회사 엘지화학 |
재조합 당단백질의 글리코실화 조절 방법
|
|
TW202440903A
(zh)
|
2015-08-04 |
2024-10-16 |
美商再生元醫藥公司 |
補充牛磺酸之細胞培養基及用法（一）
|
|
BR112018010160A8
(pt)
|
2015-11-19 |
2019-02-26 |
Shire Human Genetic Therapies |
inibidor da c1 esterase humana recombinante e usos do mesmo
|
|
WO2017114900A1
(en)
*
|
2015-12-29 |
2017-07-06 |
N.V. Nutricia |
Fermented formula with non-digestible oligosaccharides
|
|
JP7471220B2
(ja)
*
|
2017-11-30 |
2024-04-19 |
エフ・ホフマン－ラ・ロシュ・アクチェンゲゼルシャフト |
哺乳動物細胞の培養方法
|
|
SG11202104092UA
(en)
|
2018-11-13 |
2021-05-28 |
Janssen Biotech Inc |
Control of trace metals during production of anti-cd38 antibodies
|
|
US12297451B1
(en)
|
2019-10-25 |
2025-05-13 |
Regeneron Pharmaceuticals, Inc. |
Cell culture medium
|
|
US11186625B2
(en)
|
2019-12-06 |
2021-11-30 |
Regeneran Pharmaceuticals, Inc. |
Anti-VEGF protein compositions and methods for producing the same
|
|
AU2021268026A1
(en)
|
2020-05-08 |
2023-01-19 |
Regeneron Pharmaceuticals, Inc. |
VEGF traps and mini-traps and methods for treating ocular disorders and cancer
|
|
KR20230058094A
(ko)
|
2020-08-31 |
2023-05-02 |
리제너론 파아마슈티컬스, 인크. |
세포 배양 성능을 개선하고 아스파라긴 서열 변이체를 완화하기 위한 아스파라긴 공급 전략
|
|
JP2024503408A
(ja)
|
2021-01-20 |
2024-01-25 |
リジェネロン・ファーマシューティカルズ・インコーポレイテッド |
細胞培養におけるタンパク質力価の改善方法
|
|
TW202323817A
(zh)
|
2021-10-07 |
2023-06-16 |
美商再生元醫藥公司 |
Ｐｈ建模及控制之系統及方法
|
|
IL311248A
(en)
|
2021-10-07 |
2024-05-01 |
Regeneron Pharma |
PH meter calibration and repair
|
|
WO2023167855A1
(en)
|
2022-03-02 |
2023-09-07 |
Regeneron Pharmaceuticals, Inc. |
Manufacturing process for high titer antibody
|
|
WO2025219232A1
(en)
|
2024-04-15 |
2025-10-23 |
Evonik Operations Gmbh |
Application of small peptides supplemented cell culture media for improved cell performance
|